Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for Pediatric Pain Management Following Posterior Spinal Fusion Surgery
NCT07561827Phase 3Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Jun 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by University of California, San Francisco. Started Jun 2025; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07561827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07561827.